Older Clinical Trials

1 recruiting

Older Trials at a Glance

161 actively recruiting trials for older are listed on ClinicalTrialsFinder across 6 cities in 32 countries. The largest study group is Not Applicable with 96 trials, with the heaviest enrollment activity in New York, Boston, and Atlanta. Lead sponsors running older studies include Istituto Nazionale di Ricovero e Cura per Anziani, The Hong Kong Polytechnic University, and Peking University First Hospital.

Browse older trials by phase

Treatments under study

About Older Clinical Trials

Looking for clinical trials for Older? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Older trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Older clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 161 trials

Recruiting
Not Applicable

Preventing Frailty in Hospital Through Mobilizing

Frailty at Older Adults
Université de Sherbrooke80 enrolled1 locationNCT06802289
Recruiting
Not Applicable

Non-invasive Stimulation of Deep Brain Structures to Modulate Working Memory

Mild Cognitive Impairment (MCI)Older Adults (60 - 85 Years Old)
Masaryk University70 enrolled1 locationNCT07560904
Recruiting
Not Applicable

Dance Intervention to Improve Executive Function and Physical Performance in Older Adults With Cognitive Impairment

Older AdultsCognitive Impairment, Mild
Taipei Medical University Shuang Ho Hospital50 enrolled1 locationNCT07105800
Recruiting
Not Applicable

FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease

Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
University of Miami120 enrolled1 locationNCT07446777
Recruiting
Not Applicable

Increasing Physical Activity Through Social Support and Stress Resilience

Sedentary BehaviorHealthySubjective Cognitive Decline (SCD)+1 more
Arizona State University86 enrolled1 locationNCT06896825
Recruiting

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

Smoldering Multiple Myeloma (SMM)Monoclonal Gammopathy of Undetermined Significance (MGUS)Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS60 enrolled4 locationsNCT07214324
Recruiting

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

Monoclonal Gammopathy of Undetermined SignificanceSmoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center200 enrolled1 locationNCT02726750
Recruiting
Not Applicable

Postural Control in Adults

AdultsOlder Adults, BalanceOlder
University of Oklahoma30 enrolled1 locationNCT07554118
Recruiting
Not Applicable

Optimizing Care Transition Process for Older Colorectal Surgery Patients

Colorectal SurgeryOlder Adults (65 Years and Older)Care Transition
Massachusetts General Hospital30 enrolled1 locationNCT06752031
Recruiting
Phase 2Phase 3

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Indolent Systemic MastocytosisSmoldering Systemic Mastocytosis
Blueprint Medicines Corporation534 enrolled64 locationsNCT04910685
Recruiting
Not Applicable

Health Web Te@m (1.0) an Interprofessional Web-based Group Intervention Supporting Healthy Ageing

Healthy Older Adults
Luleå Tekniska Universitet27 enrolled1 locationNCT07545915
Recruiting
Not Applicable

tVNS During Motor Training in Older Adults

Older Adults
Georgia Institute of Technology32 enrolled1 locationNCT06323954
Recruiting
Not Applicable

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Memorial Sloan Kettering Cancer Center180 enrolled8 locationsNCT05640843
Recruiting
Phase 2

Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

Smoldering Plasma Cell Myeloma
Emory University68 enrolled1 locationNCT04776395
Recruiting
Not Applicable

Exploring the Acute and Dynamic Relationships Between Movement and Pain in Older Adults With Musculoskeletal Pain

PainOlder People
Indiana University40 enrolled1 locationNCT06886906
Recruiting
Not Applicable

Optimizing INtrinsic Capacity for Functional INdependence and to Impede FrailTY in Older Adults: Adaptation of the WHO-ICOPE for Healthy Ageing in Singapore

Healthy AgeingFrailty in Older AdultsIntrinsic Capacity+1 more
Sengkang General Hospital600 enrolled1 locationNCT07477561
Recruiting

Promoting Diagnosis and Management of AL in Italy (ProDigALIty)

Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaAL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia760 enrolled4 locationsNCT06383143
Recruiting

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

Monoclonal Gammopathy of Undetermined SignificanceSmoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center400 enrolled1 locationNCT05136807
Recruiting
Not Applicable

A Pilot Randomized Controlled Trial of a Social Network Intervention

Advanced CancerOlder Adults (65 Years and Older)Social Networks
University of Rochester70 enrolled1 locationNCT07393529
Recruiting
Phase 2

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

Smoldering Multiple Myeloma (SMM)Monoclonal Gammopathy of Undetermined Significance (MGUS)
Regeneron Pharmaceuticals116 enrolled20 locationsNCT06140524